Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases

被引：0

作者：

Crino, L. ^{[1
]}

Horn, L. ^{[2
]}

Felip, E. ^{[3
]}

Frontera, O. Aren ^{[4
]}

Burgio, M. ^{[1
]}

Waterhouse, D. ^{[5
]}

Blumenschein, G. ^{[6
]}

Barlesi, F. ^{[7
]}

Garassino, M. ^{[8
]}

Holgado, E. ^{[9
]}

Antonia, S. ^{[10
]}

Spigel, D. ^{[11
]}

Gainor, J. ^{[12
]}

Gettinger, S. ^{[13
]}

Geese, W. ^{[14
]}

Li, A. ^{[14
]}

Healey, D. ^{[14
]}

Ready, N. ^{[15
]}

机构：

[1] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori Irst, Meldola, Italy

[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[3] Hosp Univ Vall dHebron, Barcelona, Spain

[4] Ctr Int Estudios Clin, Santiago, Chile

[5] Oncol Hematol Care Ohc Us Oncol, Cincinnati, OH USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[7] Aix Marseille Univ, AP HM, Marseille, France

[8] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[9] Hosp Madrid, Madrid, Spain

[10] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[11] Tennessee Oncol Pllc, Sarah Cannon Res Inst, Nashville, TN USA

[12] Massachusetts Gen Hosp, Boston, MA 02114 USA

[13] Yale Comprehens Canc Ctr, New Haven, CT USA

[14] Bristol Myers Squibb, Princeton, NJ USA

[15] Duke Univ, Med Ctr, Durham, NC USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

Nivolumab; non-small cell lung cancer;

D O I：

10.1016/j.jtho.2017.09.1703

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.07-012

引用

页码：S2302 / S2302

页数：1

共 50 条

[41] Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer
Hannah A. Blair
Targeted Oncology, 2018, 13 : 399 - 407
[42] CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS PREVIOUSLY TREATED WITH ADJUVANT CHEMOTHERAPY
Valdes, Mario
Goss, Glenwood
Nicholas, Garth
Wheatley-Price, Paul
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S583 - S583
[43] Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer
Zhou, Songwen
Ren, Shengxiang
Yan, Lianghua
Zhang, Ling
Tang, Liang
Zhang, Jie
Zhou, Caicun
RESPIROLOGY, 2009, 14 (05) : 709 - 715
[44] Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
Martinez Moreno, E.
Irigoyen Medina, A.
Martinez Barroso, K.
Borregon Rivilla, M.
Alvarez Cabellos, R.
Cardenas, J. D.
Andrade Santiago, J.
Burgueno Lorenzo, I.
Trujillo Alba, B.
Chacon Lopez-Muniz, J. I.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2430 - S2430
[45] The real-world experience with nivolumab in previously treated patients with advanced non-small cell lung cancer from a cancer center in India
Abbas, Waseem
Acharya, Rudra Prasad
Pandit, Archit
Gupta, Saurabh
Rao, Ranga Raju
SOUTH ASIAN JOURNAL OF CANCER, 2020, 9 (01) : 50 - 52
[46] Nivolumab monotherapy in patients with previously treated advanced non-small cell lung cancer (NSCLC) in routine clinical practice in a Spanish center
Mielgo, X.
Toro, P.
Ruiz-Gimenez, L.
Olier, C.
Perez, M.
Rosero, A.
Camara, J. C.
Hernando, S.
Hurtado, A.
Jara, C.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S135 - S135
[47] Nivolumab versus pembrolizumab in previously-treated advanced non-small cell lung cancer patients: A propensity-matched real-world analysis
Torasawa, Masahiro
Yoshida, Tatsuya
Yagishita, Shigehiro
Shimoda, Yukiko
Shirasawa, Masayuki
Matsumoto, Yuji
Masuda, Ken
Shinno, Yuki
Okuma, Yusuke
Goto, Yasushi
Horinouchi, Hidehito
Yamamoto, Noboru
Takahashi, Kazuhisa
Ohe, Yuichiro
LUNG CANCER, 2022, 167 : 49 - 57
[48] The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens
Fossella, FV
Rigas, J
SEMINARS IN ONCOLOGY, 1999, 26 (03) : 9 - 12
[49] Docetaxel for previously treated non-small-cell lung cancer
Fossella, FV
ONCOLOGY-NEW YORK, 2002, 16 (06): : 45 - 51
[50] Bortezomib ± docetaxel in previously treated advanced non-small cell lung cancer: Interim analysis of a phase 2 study
Fanucchi, Michael
Belt, Robert
Fossella, Frank
Natale, Ronald
Robert, Francisco
Fidias, Panos
Kelly, Karen
Kashala, Oscar
Schenkein, David
Schiller, Joan
ANNALS OF ONCOLOGY, 2004, 15 : 170 - 170

← 1 2 3 4 5 →